免疫检查点阻塞反应的临床基因组决定因素在头部和部状细胞癌中

Cristina Valero1, Mahdi Golkaram2, Joris L Vos1

  • 1Head and Neck Service, Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, USA.

概括

新的分子亚型和临床基因组分类器改善了在复发性头癌中免疫检查点阻塞反应的预测,仅仅超越了瘤突变负担.